Literature DB >> 24255632

Progressive Increase of Regulatory T Cells and Decrease of CD8+ T Cells and CD8+ T Cells/Regulatory T Cells Ratio during Colorectal Cancer Development.

Tae Jung Jang1.   

Abstract

BACKGROUND: We examined the distribution of CD8+ T cells and regulatory T cells (Tregs), measured the CD8+ T cell/Tregs ratio, investigated the relationship between Tregs and cyclooxygenase-2 (COX-2) expression during colorectal cancer (CRC) development.
METHODS: We performed immunohistochemical staining for CD8, forkhead box P3, E-cadherin, and COX-2 in 32 cases of invasive CRC, 10 cases of intramucosal CRC, 27 cases of high-grade tubular adenoma, 22 cases of low-grade tubular adenoma, and 32 cases of non-neoplastic conditions.
RESULTS: We observed a progressive increase in Tregs, and a decrease in CD8+ T cells and the CD8+ T cells/Tregs ratio during CRC development. The alterations were most severe in high-grade tubular adenoma and CRC. COX-2 expression was positively associated with Tregs infiltration. The degree of T cell infiltration differed among tumor compartment and the ratio in the tumor center was the lowest of all areas. The ratio and number of CD8+ T cells in the tumor center and the invasive front of invasive CRC were associated with gender, differentiation, node metastasis and tumor budding.
CONCLUSIONS: Alteration in the distribution of both CD8+T cells and Tregs may contribute to the generation of an immune environment suitable for the development and progression of CRC.

Entities:  

Keywords:  CD8+ T cell; Colorectal neoplasms; Cyclooxygenase-2; T-lymphocytes, regulatory

Year:  2013        PMID: 24255632      PMCID: PMC3830991          DOI: 10.4132/KoreanJPathol.2013.47.5.443

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  27 in total

1.  Tumor differentiation-dependent local immunity in human head and neck cancers.

Authors:  I Arany; K Adler-Storthz; Z Chen; S K Tyring; M M Brysk
Journal:  Cancer Lett       Date:  1998-01-30       Impact factor: 8.679

2.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

3.  Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.

Authors:  Sun-Young Lee; Katsuya Miyai; Hye Seung Han; Dae-Yong Hwang; Moo Kyung Seong; Heekyung Chung; Barbara H Jung; Bikash Devaraj; Kathleen L McGuire; John M Carethers
Journal:  Dig Dis Sci       Date:  2011-07-20       Impact factor: 3.199

4.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

Review 5.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

6.  Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.

Authors:  Hiroyuki Suzuki; Nobuhito Chikazawa; Takehiko Tasaka; Junji Wada; Akio Yamasaki; Yoshiki Kitaura; Masae Sozaki; Masao Tanaka; Hideya Onishi; Takashi Morisaki; Mitsuo Katano
Journal:  Cancer Immunol Immunother       Date:  2009-11-12       Impact factor: 6.968

7.  CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer.

Authors:  A Lugli; E Karamitopoulou; I Panayiotides; P Karakitsos; G Rallis; G Peros; G Iezzi; G Spagnoli; M Bihl; L Terracciano; I Zlobec
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

Review 8.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.

Authors:  Harry H Yoon; Jared M Orrock; Nathan R Foster; Daniel J Sargent; Thomas C Smyrk; Frank A Sinicrope
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

10.  Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.

Authors:  J A Keene; J Forman
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  15 in total

1.  Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).

Authors:  Qiushi Wang; Xinghua Gao; Zhe Yuan; Zhe Wang; Yiming Meng; Yan Cao; Nicolas P Plotnikoff; Noreen Griffin; Fengping Shan
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

3.  Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients.

Authors:  Akihiro Yoshimura; Tadaaki Yamada; Yusuke Okuma; Rui Kitadai; Takayuki Takeda; Takanori Kanematsu; Hisatsugu Goto; Hiroto Yoneda; Taishi Harada; Yutaka Kubota; Takahiro Yamada; Koji Date; Shinsuke Shiotsu; Kazuhiro Nagata; Yusuke Chihara; Yoshiko Kaneko; Junji Uchino; Yasuhiko Nishioka; Koichi Takayama
Journal:  Transl Lung Cancer Res       Date:  2019-08

4.  Preinvasive Colorectal Lesions of African Americans Display an Immunosuppressive Signature Compared to Caucasian Americans.

Authors:  Kristin Wallace; Georges J Nahhas; Christine Bookhout; David N Lewin; Chrystal M Paulos; Nana Nikolaishvili-Feinberg; Stephanie M Cohen; Silvia Guglietta; Ali Bakhtiari; E Ramsay Camp; Elizabeth G Hill; John A Baron; Jennifer D Wu; Alexander V Alekseyenko
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

5.  Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.

Authors:  Shuping Zhang; Xing Ke; Suyun Zeng; Meng Wu; Jianfang Lou; Lei Wu; Peijun Huang; Lei Huang; Fang Wang; Shiyang Pan
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

6.  The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal Lesions.

Authors:  Antonella Maglietta; Rosalia Maglietta; Teresa Staiano; Ramona Bertoni; Nicola Ancona; Giancarlo Marra; Leonardo Resta
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

7.  PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis.

Authors:  Yi Que; Wei Xiao; Yuan-Xiang Guan; Yao Liang; Shu-Mei Yan; Huo-Ying Chen; Qiao-Qiao Li; Bu-Shu Xu; Zhi-Wei Zhou; Xing Zhang
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

8.  Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis.

Authors:  Robert E Brown; Robert L Hunter; Shen-An Hwang
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

9.  Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology.

Authors:  Kristin Wallace; Georges J El Nahas; Christine Bookhout; Jessica E Thaxton; David N Lewin; Nana Nikolaishvili-Feinberg; Stephanie M Cohen; J Grant Brazeal; Elizabeth G Hill; Jennifer D Wu; John A Baron; Alexander V Alekseyenko
Journal:  Cancer Prev Res (Phila)       Date:  2021-08-02

Review 10.  Colorectal cancer prevention: Immune modulation taking the stage.

Authors:  Rochelle Fletcher; Yi-Jun Wang; Robert E Schoen; Olivera J Finn; Jian Yu; Lin Zhang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 11.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.